Voloridge Investment Management’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-352,428
| Closed | -$5.42M | – | 1077 |
|
|
2025
Q4 | $5.42M | Sell |
352,428
-77,229
| -18% | -$851K | 0.02% | 746 |
|
|
2025
Q3 | $4.27M | Buy |
429,657
+191,763
| +81% | +$2M | 0.01% | 784 |
|
|
2025
Q2 | $2.36M | Buy |
+237,894
| New | +$2.51M | 0.01% | 924 |
|
|
2022
Q2 | – | Sell |
-280,168
| Closed | -$3.04M | – | 1479 |
|
|
2022
Q1 | $3.04M | Sell |
280,168
-311,988
| -53% | -$3.79M | 0.02% | 817 |
|
|
2021
Q4 | $8.33M | Sell |
592,156
-55,085
| -9% | -$906K | 0.05% | 522 |
|
|
2021
Q3 | $12.4M | Buy |
647,241
+630,244
| +3,708% | +$8.37M | 0.08% | 353 |
|
|
2021
Q2 | $167K | Sell |
16,997
-45,041
| -73% | -$409K | ﹤0.01% | 1569 |
|
|
2021
Q1 | $610K | Buy |
+62,038
| New | +$511K | ﹤0.01% | 1139 |
|
|
2020
Q3 | – | Sell |
-16,400
| Closed | -$145K | – | 1300 |
|
|
2020
Q2 | $145K | Buy |
+16,400
| New | +$82.9K | ﹤0.01% | 1214 |
|
|
2019
Q2 | – | Sell |
-73,795
| Closed | -$539K | – | 825 |
|
|
2019
Q1 | $539K | Buy |
+73,795
| New | +$721K | 0.02% | 642 |
|
|
2017
Q4 | – | Sell |
-66,448
| Closed | -$1.43M | – | 507 |
|
|
2017
Q3 | $1.43M | Buy |
+66,448
| New | +$1.05M | 0.03% | 302 |
|
Other funds holding DVAX
Voloridge Investment Management's DVAX Position: Q1 2026 in Review
Voloridge Investment Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 352,428 shares — an estimated $5.42M sold.
Voloridge Investment Management first reported a position in DVAX in Q3 2017 and held it in 11 quarters. The position peaked at $12.4M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Voloridge Investment Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Voloridge Investment Management sold 352,428 Dynavax Technologies shares in Q1 2026, an estimated $5.42M.
- Voloridge Investment Management first reported a position in Dynavax Technologies in Q3 2017 and held it in 11 quarters.
- Voloridge Investment Management's Dynavax Technologies position peaked at $12.4M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.